BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230907T080000
DTEND;TZID=America/New_York:20230908T170000
DTSTAMP:20260403T215437
CREATED:20221108T182939Z
LAST-MODIFIED:20221108T182939Z
UID:6996-1694073600-1694192400@carb-x.org
SUMMARY:World AMR Congress 2023
DESCRIPTION:THE WORLD’S LARGEST AMR CONFERENCE FOR ALL STAKEHOLDERS COMBATING ANTI-MICROBIAL RESISTANCE
URL:https://carb-x.org/event/world-amr-congress-2023/
LOCATION:Pennsylvania Convention Center\, Philadelphia\, PA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230813T080000
DTEND;TZID=America/New_York:20230817T170000
DTSTAMP:20260403T215437
CREATED:20230419T194204Z
LAST-MODIFIED:20230419T194204Z
UID:7466-1691913600-1692291600@carb-x.org
SUMMARY:ACS Fall Meeting - The Future of Antibiotic Drug Discovery
DESCRIPTION:Where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge.
URL:https://carb-x.org/event/acs-fall-meeting-the-future-of-antibiotic-drug-discovery/
LOCATION:San Francisco\, CA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230615T080000
DTEND;TZID=America/New_York:20230619T170000
DTSTAMP:20260403T215437
CREATED:20230419T193615Z
LAST-MODIFIED:20230419T193817Z
UID:7463-1686816000-1687194000@carb-x.org
SUMMARY:ASM Microbe 2023
DESCRIPTION:Join thousands of scientists\, researchers and healthcare professionals in your field\, who are all traveling to Houston\, TX from June 15-19 for the largest microbial sciences gathering in the world! Andy Weir\, John Nkengasong and Edward Holmes are just some of the world-renowned speakers lined up in ASM Microbe’s cutting-edge scientific program. \nPlus\, do you have late-breaking research? There is still time to join our robust scientific program! Emerging Abstract Submissions Opens April 4. Don’t miss the opportunity to present your research and learn about the latest science from experts and leaders in your field. \nASM Microbe 2023 will cover: \n\nDisaster Microbiology.\nEmerging Infections – What is the Next pandemic? (Focus on Nipah and Marburg).\nNatural Product Discovery and Synthesis.\nThe Next Generation Antifungal Agents: Clinical Application and Resistance.\nCombating the Climate Crisis with Critters: Microbial Carbon Capture.\nPowering the Future: Applied Microbiology in the Energy Industry.\nEquity and Access in Laboratory Diagnostics.\nMicrobiome Management in a Changing World.\nNew Perspectives on Phage Therapy to Treat Multidrug Resistant Infections.\nBeyond Academia: Fulfilling Microbiology Careers Outside the Tenure Track.\nThe Perks of Being Squishy: Archaea as a Skillful Mechanoresponsive Machine.\nWhat is the Microbiota Really Doing in Neuroinflammatory Diseases?\nAnd so much more!
URL:https://carb-x.org/event/asm-microbe-2023/
LOCATION:George R. Brown Convention Center\, Houston\, TX
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230612T080000
DTEND;TZID=America/New_York:20230613T170000
DTSTAMP:20260403T215437
CREATED:20230419T193241Z
LAST-MODIFIED:20230419T193241Z
UID:7460-1686556800-1686675600@carb-x.org
SUMMARY:Boston Bacterial Meeting 2023
DESCRIPTION:The meeting will be held at the Harvard Science Center\, 1 Oxford St\, Cambridge\, MA 02138. Please visit our Directions page for information on public transit and parking. \n\n\n\n\nThe keynote address for BBM 2023 will be delivered by Dr. Kumaran Ramamurthi from the NIH. Dr. Ramamurthi is a renowned bacterial cell biologist who has made important contributions to our understanding of how morphogenetic proteins localize to specific sites and drive essential processes such as spore formation and cell division. Please visit our Keynote Speaker page for more information about his career and accomplishments. \n\n\n\n\n\n\n\n\n\n\n\nAbout BBM\n\n\n\n\nBBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard\, Kit Pogliano and Karen McGovern\, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM\, now in its 29th year\, has proven to be a vibrant meeting\, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots\, the conference is being planned and organized by a committee of students\, postdocs\, and other early career researchers. This year\, the organizational committee is co-chaired by Alam García-Heredia\, a postdoc in Alan Grossman’s lab at MIT\, and Shailab Shrestha\, a graduate student in Aimee Shen’s lab at Tufts.
URL:https://carb-x.org/event/boston-bacterial-meeting-2023/
LOCATION:Harvard Science Center
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20230610T150000
DTEND;TZID=Asia/Kolkata:20230610T173000
DTSTAMP:20260403T215437
CREATED:20230522T134117Z
LAST-MODIFIED:20230522T134117Z
UID:7583-1686409200-1686418200@carb-x.org
SUMMARY:Engaging the Pharmaceutical Industry in Joint Efforts to Tackle ANTIMICROBIAL RESISTANCE
DESCRIPTION:A webinar focused on AMR issues pertinent to India such as: \n\nWhat is the current status of antibiotic development in the pipeline\, both in India and globally?\nWhat are some potential strategies or incentives to stimulate anti-infective development in India?\nWhat role can the Indian pharmaceutical industry play in global efforts to develop new anti-infectives?\nHow can we ensure the availability and affordability of new antibiotics in India while maintaining their responsible use?\n\nRegister here to join the conversation.
URL:https://carb-x.org/event/engaging-the-pharmaceutical-industry-in-joint-efforts-to-tackle-antimicrobial-resistance/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230605T080000
DTEND;TZID=America/New_York:20230608T170000
DTSTAMP:20260403T215437
CREATED:20230419T193118Z
LAST-MODIFIED:20230419T193118Z
UID:7458-1685952000-1686243600@carb-x.org
SUMMARY:BIO Boston 2023
DESCRIPTION:Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire\, honor\, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future.
URL:https://carb-x.org/event/bio-boston-2023/
LOCATION:Boston Convention Center\, 415 Summer St\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230521T080000
DTEND;TZID=America/New_York:20230530T170000
DTSTAMP:20260403T215437
CREATED:20221214T152058Z
LAST-MODIFIED:20221214T152058Z
UID:7105-1684656000-1685466000@carb-x.org
SUMMARY:76th World Health Assembly
DESCRIPTION:The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions of the World Health Assembly are to determine the policies of the Organization\, appoint the Director-General\, supervise financial policies\, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva\, Switzerland.
URL:https://carb-x.org/event/76th-world-health-assembly/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230518T080000
DTEND;TZID=America/New_York:20230519T170000
DTSTAMP:20260403T215437
CREATED:20230419T192936Z
LAST-MODIFIED:20230419T192936Z
UID:7456-1684396800-1684515600@carb-x.org
SUMMARY:BSAC Spring Conference
DESCRIPTION:ADDRESSING THE AMR BURDEN IN EVERYDAY PRACTICE
URL:https://carb-x.org/event/bsac-spring-conference-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230517T133500
DTEND;TZID=America/New_York:20230517T142000
DTSTAMP:20260403T215437
CREATED:20230502T182906Z
LAST-MODIFIED:20230502T182906Z
UID:7546-1684330500-1684333200@carb-x.org
SUMMARY:Financial Times Live Panel: National health security – Addressing rising threats
DESCRIPTION:The coronavirus pandemic was a wake-up call for those inclined to ignore emerging health threats. Looking to the future\, whether it be another virus\, mental health\, or noncommunicable diseases such as diabetes and dementia\, the US must consider its options to avoid or at least minimize the impact of health threats with the potential to cause even more pain if ignored. \n\nHow can stakeholders work together to prepare for epidemics and pandemics of the future?\nWhat can be done to support health systems in handling the rise of chronic conditions such as obesity and dementia?\nWhat advances are we seeing in treatment of increasingly prevalent conditions such as Alzheimer’s\, diabetes and cancer?\nAs recognition and understanding of mental health evolves\, how could treatments change?\n\nSpeakers: \nKevin Outterson\, Austin B. Fletcher Professor\, Boston University\, Executive Director and Principal Investigator\, CARB-X \nRasmus Besch Hansen\, CEO and Founder\, Airfinity \nOlivier Bogillot\, Head of US General Medicines\, Sanofi \nJulie Gerberding\, CEO\, Foundation for the National Institutes of Health \nAndrew Jack\, Global Education Editor\, Financial Times
URL:https://carb-x.org/event/financial-times-live-panel-national-health-security-addressing-rising-threats/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230421T080000
DTEND;TZID=America/New_York:20230421T090000
DTSTAMP:20260403T215437
CREATED:20230301T185258Z
LAST-MODIFIED:20230301T185634Z
UID:7285-1682064000-1682067600@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #2
DESCRIPTION:Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds.
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-2-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230420T180000
DTEND;TZID=America/New_York:20230420T190000
DTSTAMP:20260403T215437
CREATED:20230301T184621Z
LAST-MODIFIED:20230301T185709Z
UID:7283-1682013600-1682017200@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #1
DESCRIPTION:Register here for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds.
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-1-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230415T080000
DTEND;TZID=America/New_York:20230418T170000
DTSTAMP:20260403T215437
CREATED:20221101T211019Z
LAST-MODIFIED:20221101T211039Z
UID:6954-1681545600-1681837200@carb-x.org
SUMMARY:ECCMID 2023
DESCRIPTION:ECCMID invites you to the 33rd European Congress of Clinical Microbiology & Infectious Diseases\, which will take place as a hybrid event both online and in Copenhagen\, Denmark on 15 – 18 April 2023.
URL:https://carb-x.org/event/eccmid-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230316T080000
DTEND;TZID=America/New_York:20230317T170000
DTSTAMP:20260403T215437
CREATED:20221101T210819Z
LAST-MODIFIED:20221101T210819Z
UID:6952-1678953600-1679072400@carb-x.org
SUMMARY:7th AMR Conference
DESCRIPTION:The #AMRconference is a platform for SMEs\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. \nThe “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business\, science\, clinics\, finance\, regulatory affairs and intellectual property. \n\n\n\n\n\n\n\n\n\n\n\n\nThe BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015\, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of more than 60 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the AMR Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders.
URL:https://carb-x.org/event/7th-amr-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230303T080000
DTEND;TZID=America/New_York:20230316T170000
DTSTAMP:20260403T215437
CREATED:20230131T180509Z
LAST-MODIFIED:20230131T180509Z
UID:7234-1677830400-1678986000@carb-x.org
SUMMARY:An Unfinished Life: The True Impact of Antibiotic Resistance
DESCRIPTION:Join Australia’s mission against superbugs with the Australian Premiere of Salt in my Soul followed by an interactive discussion forum with the scientists\, clinicians and policy makers working at the coalface of antimicrobial resistance. \nSpeakers include CARB-X’s Chief Scientist\, Dr. Richard Alm \nMarch 3rd: Perth \nMarch 7th: Brisbane \nMarch 10th: Adelaide \nMarch 14th: Melbourne \nMarch 16th: Sydney
URL:https://carb-x.org/event/an-unfinished-life-the-true-impact-of-antibiotic-resistance/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230228T080000
DTEND;TZID=America/New_York:20230302T170000
DTSTAMP:20260403T215437
CREATED:20221214T151438Z
LAST-MODIFIED:20221214T151943Z
UID:7103-1677571200-1677776400@carb-x.org
SUMMARY:BIOCOM 2023
DESCRIPTION:The Premier Partnering Event of the Year\nThis conference is an exclusive global partnering forum that brings together senior executives\, bankers\, venture capitalists\, and business development professionals from leading pharmaceutical and biotech companies. Join us next February 2023\, where industry leaders will debate current trends\, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.
URL:https://carb-x.org/event/biocom-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230221T103000
DTEND;TZID=America/New_York:20230221T113000
DTSTAMP:20260403T215437
CREATED:20230209T210601Z
LAST-MODIFIED:20230209T210601Z
UID:7245-1676975400-1676979000@carb-x.org
SUMMARY:Webinar: Addressing Antimicrobial Resistance Through the Pandemic Instrument
DESCRIPTION:This moment provides an important opportunity for addressing the global threat of antimicrobial resistance (AMR). \nThis month\, the Intergovernmental Negotiating Body (INB) –– the entity established by the World Health Organization (WHO) to draft and negotiate a pandemic instrument –– will meet to consider and negotiate the zero draft of the WHO international instrument on pandemic prevention\, preparedness and response. This webinar will contribute to discussions on the pandemic instrument and the opportunity to comprehensively address the full range of pandemic threats\, including AMR. AMR already kills over 1 million people annually and contributes to millions more deaths around the world – a toll that is disproportionately borne by LMICs.  \nJoin us for a discussion and exchange inspired by the forthcoming Symposium Issue of the Journal of Law\, Medicine & Ethics (JLME) on Addressing Antimicrobial Resistance through the Pandemic Instrument\, guest edited by Kevin Outtersen (Boston University\, CARB-X) and Global Strategy Lab’s Susan Rogers Van Katwyk and Steven J. Hoffman. The webinar will feature a roundtable format\, a panel of researchers and experts on AMR policy and will be followed by a Q&A session with the audience.
URL:https://carb-x.org/event/webinar-addressing-antimicrobial-resistance-through-the-pandemic-instrument/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230221T080000
DTEND;TZID=America/New_York:20230222T170000
DTSTAMP:20260403T215437
CREATED:20221213T181639Z
LAST-MODIFIED:20221213T181639Z
UID:7093-1676966400-1677085200@carb-x.org
SUMMARY:2023 UNIVERSAL HEALTH COVERAGE (UHC) IN AN ERA OF ANTIMICROBIAL RESISTANCE (AMR) AND PANDEMICS CONFERENCE
DESCRIPTION:Built upon the outcomes of the 2018 High-level Meeting spearheaded by ASEF\, the high-level conference on “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics” is co-organised by Asia-Europe Foundation (ASEF)\, AMR Clinical Reference Center and the Ministry of Foreign Affairs of Japan. The conference will take place on 21-22 February 2023 in Tokyo\, Japan.   \nThe overall aim of this conference is to facilitate a much-needed dialogue between governments and other stakeholders on practical ways to integrate a concern for AMR into UHC. Unlike short-term measures and funding schemes\, health systems are here to stay. Accordingly\, the conference will discuss sustainable actions on AMR using the health system approach. Actionable AMR strategies that address the need to support high quality science and provide incentives to develop and produce new antimicrobials will also be considered. The conference will explore the links between mitigating AMR under UHC and pandemic preparedness. Last but not least\, possible international collaborations and effective coordination mechanisms will also be sought\, as AMR cannot be solved by a single country on its own.  \nThe conference will bring together senior-level health officials who are working in the areas of UHC\, AMR\, and Pandemic Preparedness and Response (PPR). The conference will feature presentations and panel discussions on topical subjects\, such as about innovative ideas on R&D and commercialisation of antimicrobials for sustainability\, as well as group discussions on priorities for international cooperation between Asia and Europe to support progress towards sustainable UHC while containing risks of emerging infectious diseases\, including AMR.  \nTo learn more about the conference background\, its audience\, partners\, and other details\, please click here. \nThis high-level conference is an invitation-only event. 
URL:https://carb-x.org/event/2023-universal-health-coverage-uhc-in-an-era-of-antimicrobial-resistance-amr-and-pandemics-conference/
LOCATION:Tokyo Station Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20230202T150000
DTEND;TZID=Europe/Berlin:20230202T170000
DTSTAMP:20260403T215437
CREATED:20221223T163438Z
LAST-MODIFIED:20221223T163438Z
UID:7162-1675350000-1675357200@carb-x.org
SUMMARY:Clinical Workshop on Small Molecules and Biologicals
DESCRIPTION:The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals\, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one\, therefore knowledge of the first part or other workshops of this series is not required. \n  \nThe workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies\, ethics committee\, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct. \n  \nThe workshop will be held as a weekly webinar over the course of three weeks with the following topics: \n\nSession 1: Introduction on clinical development\nThursday 19th January 2023\, start at 3 pm (CET)\nSession 2: Role of ethics committee and supporting infrastructures\nThursday 26th January 2023\, start at 3 pm (CET)\nSession 3: Regulatory background of clinical studies\nThursday 2nd February 2023\, start at 3 pm (CET)\n\n  \nFor further information\, please see the agenda attached. \n  \nFor registration\, please contact OSRA@PEI.de until 12th  of January 2023 including if you are affiliated with DZIF or CARB-X.
URL:https://carb-x.org/event/clinical-workshop-on-small-molecules-and-biologicals-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230201T080000
DTEND;TZID=America/New_York:20230202T170000
DTSTAMP:20260403T215437
CREATED:20221214T151039Z
LAST-MODIFIED:20221214T151039Z
UID:7101-1675238400-1675357200@carb-x.org
SUMMARY:ANTIMICROBIAL CHEMOTHERAPY CONFERENCE (ACC 2023)
DESCRIPTION:This virtual conference is jointly organised by BSAC and GARDP.  For ACC2023\, the collaborating organisations are Africa CDC and ReAct Africa.
URL:https://carb-x.org/event/antimicrobial-chemotherapy-conference-acc-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20230126T150000
DTEND;TZID=Europe/Berlin:20230126T170000
DTSTAMP:20260403T215437
CREATED:20221223T163355Z
LAST-MODIFIED:20221223T163355Z
UID:7160-1674745200-1674752400@carb-x.org
SUMMARY:Clinical Workshop on Small Molecules and Biologicals
DESCRIPTION:The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals\, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one\, therefore knowledge of the first part or other workshops of this series is not required. \n  \nThe workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies\, ethics committee\, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct. \n  \nThe workshop will be held as a weekly webinar over the course of three weeks with the following topics: \n\nSession 1: Introduction on clinical development\nThursday 19th January 2023\, start at 3 pm (CET)\nSession 2: Role of ethics committee and supporting infrastructures\nThursday 26th January 2023\, start at 3 pm (CET)\nSession 3: Regulatory background of clinical studies\nThursday 2nd February 2023\, start at 3 pm (CET)\n\n  \nFor further information\, please see the agenda attached. \n  \nFor registration\, please contact OSRA@PEI.de until 12th  of January 2023 including if you are affiliated with DZIF or CARB-X.
URL:https://carb-x.org/event/clinical-workshop-on-small-molecules-and-biologicals-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230120T190000
DTEND;TZID=America/New_York:20230120T200000
DTSTAMP:20260403T215437
CREATED:20221223T153345Z
LAST-MODIFIED:20221223T153604Z
UID:7150-1674241200-1674244800@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #2
DESCRIPTION:Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20230119T150000
DTEND;TZID=Europe/Berlin:20230119T170000
DTSTAMP:20260403T215437
CREATED:20221223T163310Z
LAST-MODIFIED:20221223T163310Z
UID:7158-1674140400-1674147600@carb-x.org
SUMMARY:Clinical Workshop on Small Molecules and Biologicals
DESCRIPTION:The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals\, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one\, therefore knowledge of the first part or other workshops of this series is not required. \n  \nThe workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies\, ethics committee\, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct. \n  \nThe workshop will be held as a weekly webinar over the course of three weeks with the following topics: \n\nSession 1: Introduction on clinical development\nThursday 19th January 2023\, start at 3 pm (CET)\nSession 2: Role of ethics committee and supporting infrastructures\nThursday 26th January 2023\, start at 3 pm (CET)\nSession 3: Regulatory background of clinical studies\nThursday 2nd February 2023\, start at 3 pm (CET)\n\n  \nFor further information\, please see the agenda attached. \n  \nFor registration\, please contact OSRA@PEI.de until 12th  of January 2023 including if you are affiliated with DZIF or CARB-X.
URL:https://carb-x.org/event/clinical-workshop-on-small-molecules-and-biologicals/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230119T080000
DTEND;TZID=America/New_York:20230119T090000
DTSTAMP:20260403T215437
CREATED:20221223T153126Z
LAST-MODIFIED:20221223T153126Z
UID:7148-1674115200-1674118800@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #1
DESCRIPTION:Register for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds: Webinar Registration – Zoom
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-1/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221213T080000
DTEND;TZID=America/New_York:20221213T170000
DTSTAMP:20260403T215437
CREATED:20220722T204701Z
LAST-MODIFIED:20220722T204701Z
UID:6485-1670918400-1670950800@carb-x.org
SUMMARY:Infection 2022: BSAC Winter Conference\, Nouveau Frontiers in Infection: This time its personal!
DESCRIPTION:
URL:https://carb-x.org/event/infection-2022-bsac-winter-conference-nouveau-frontiers-in-infection-this-time-its-personal/
LOCATION:Royal College of Physicians\, London
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221206T080000
DTEND;TZID=America/New_York:20221206T170000
DTSTAMP:20260403T215437
CREATED:20221128T203638Z
LAST-MODIFIED:20221128T203638Z
UID:7053-1670313600-1670346000@carb-x.org
SUMMARY:MassBio Innovation Week
DESCRIPTION:Join us for our first ever Innovation Week! Each day of Innovation Week we will showcase emerging companies or academic research that could have a transformational impact on all patients. Our goal is to use our global platform to connect these changemakers to an audience of prospective partners\, investors\, stakeholders\, and other ecosystem leaders that can help them take the next step with their science. \nIf you are a founder or researcher who is interested in being featured and are working in the oncology\, infectious disease\, cardiovascular and metabolic disease\, rare disease\, or neuroscience therapeutic areas\, we encourage you to apply to be a featured participant. \nSpecifically\, we plan to highlight founders and researchers: \n\nFrom traditionally under-represented backgrounds in the industry – including people of color\, women\, the LGBTQIA+ community\, and people with disabilities\nWho are working towards greater health equity\, clinical diversity\, and/or who are making an impact in underserved disease areas or diseases that adversely affect underrepresented communities\n\nWe will feature just five companies or researchers each day of the week (Monday\, Dec 5\, 2022: Oncology\, Tuesday\, Dec 6 2022: Infectious Diseases (specifically\, AMR)\, Wednesday\, Dec 7\, 2022: Cardiovascular and metabolic diseases and Rare Diseases\, Thursday\, Dec 8\, 2022: Neuroscience). Each founder will have 20 minutes to present\, with 5 minutes of audience Q&A following their presentation; presentations will happen live and via Zoom webinar each afternoon EST. \n  \nFeatured speakers include Dr. Erin Duffy\, Chief of Research & Development of CARB-X
URL:https://carb-x.org/event/massbio-innovation-week/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221124T080000
DTEND;TZID=America/New_York:20221125T170000
DTSTAMP:20260403T215437
CREATED:20221101T210717Z
LAST-MODIFIED:20221101T210717Z
UID:6949-1669276800-1669395600@carb-x.org
SUMMARY:3rd Global High-Level Ministerial Conference on AMR
DESCRIPTION:The Sultanate of Oman is hosting the 3rd High-level Ministerial Conference on Antimicrobial Resistance (AMR) in Muscat\, Oman on 24 and 25 November 2022 to accelerate tackling AMR at the national\, regional\, and global levels and to enhance international cooperation. It will build on the success of the two previous High-level Ministerial Conferences held in the Netherlands in 2014 and 2019. High-level participation will include ministers of health\, agriculture\, animal health\, the environment\, and finance\, as well as policymakers\, key global experts\, and representatives from the private sector\, civil society\, research institutions\, and multilateral organizations. The conference will be conducted through keynote speeches\, case studies to demonstrate best practices\, and interactive discussions between participants. The conference will be an opportunity for an interactive dialogue on One Health action to address the AMR pandemic. \nThe Third Global High-level Ministerial Conference on Antimicrobial Resistance will center on the theme of paving the way to bold and specific political commitments in the United Nations General Assembly High Level Meeting on AMR (UNGA HLM) in 2024. It is the intention of the Government of Oman that the expected outcomes of the Conference\, including the content of the Manifesto\, will inform the upcoming UNGA HLM in 2024.
URL:https://carb-x.org/event/3rd-global-high-level-ministerial-conference-on-amr/
LOCATION:Muscat\, Sultanate of Oman
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221115T080000
DTEND;TZID=America/New_York:20221116T170000
DTSTAMP:20260403T215437
CREATED:20221101T210516Z
LAST-MODIFIED:20221101T210516Z
UID:6947-1668499200-1668618000@carb-x.org
SUMMARY:9th Nikkei FT Communicable Diseases Conference
DESCRIPTION:The outbreak of COVID-19 has not only revealed Japan’s lag in such areas including R&D of domestic vaccines and medicines\, digitalization of its medical systems\, and crisis management system itself\, but also revealed the vulnerability in the global health system. Developing countries are also confronted with infection controls\, which results in virus mutation and spread malaria\, tuberculosis\, and many other emerging and re-emerging communicable diseases. \nNikkei Inc. has been organizing the annual Nikkei FT Communicable Diseases Conference since 2014\, gathering internationally renowned experts in the field; representatives of the private sector\, academia and high-ranking government officials responsible for health\, both within and outside Japan. \nThe 9th Conference is to be held on 15th -16th November\, discussing how the global health communities should fight against communicable diseases\, and how Japan can maximize its contribution. Through Nikkei group’s diverse media network\, the concrete and practical action plans that had been proposed from the conference will be disseminated globally.
URL:https://carb-x.org/event/9th-nikkei-ft-communicable-diseases-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221115T080000
DTEND;TZID=America/New_York:20221116T170000
DTSTAMP:20260403T215437
CREATED:20220722T204522Z
LAST-MODIFIED:20220831T155348Z
UID:6482-1668499200-1668618000@carb-x.org
SUMMARY:BARDA Industry Day 2022
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA)\, a component of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR)\, invites you to participate in our annual conference to learn about U.S. Government medical countermeasure priorities\, interact with the BARDA and ASPR teams\, and network with public and private sector colleagues. \nFor more information regarding the above offices\, and their missions\, please visit the following links: BARDA\, ASPR\, and HHS. \nThis year’s lineup will have an assortment of BARDA program briefings\, featured speakers\, special sessions\, and breakout sessions addressing our efforts towards our four strategic goals of enhancing preparedness\, response\, and partnerships against future threats. There will be a renewed focus on strengthening connections\, networking\, and collaboration within our virtual event environment. \nStay in the loop for BID 2022 announcements and details by following BARDA on Twitter\, LinkedIn and Instagram and visiting our website. \nWe look forward to seeing you online on November 15-16\, 2022!
URL:https://carb-x.org/event/barda-industry-day-2022/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221107T080000
DTEND;TZID=America/New_York:20221209T170000
DTSTAMP:20260403T215437
CREATED:20221103T174439Z
LAST-MODIFIED:20221103T191507Z
UID:6972-1667808000-1670605200@carb-x.org
SUMMARY:Fundamentals of in vitro diagnostic product development: Making the move from academic and entrepreneurial R&D to product development webinar series
DESCRIPTION:Are you an India-based academic\, R&D manager or scientist interested in transitioning your #AMR #bacterial #diagnostic into an IVD product? \n🖥️ Register for the 5-part seminar series from November 7 through December 9. \nTopics include: \n*️ (11 Nov.) Product development process \n*️ (18 Nov.) Design controls \n*️ (21 Nov.) Real-life stories: Academia to commercialization \n*️ (2 Dec.) Quality management and good laboratory practices \n*️ (9 Dec.) Case study: Why the fundamentals matter \nQ&A Panelists: \n*️ Taslimarif Saiyed\, Director and CEO\, C-CAMP\n*️ Rangarajan Sampath\, Senior Vice President and Head\, Center for Innovation in Diagnostics\, Siemens Healthineers\n*️ Tara deBoer\, Chief Executive Officer\, BioAmp Diagnostics\n*️ Debkishore Mitra\, Chief Technology Officer and co-founder\, Lucira Health\n*️ Chandrasekhar Nair\, Director\, Molbio Diagnostics\n*️ Peter J. Dailey\, Senior Technical Officer\, FIND \nModerated by Betsy Wonderly Trainor\, Diagnostics Alliance Director\, CARB-X \n47% of the global population does not have access to basic diagnostics. To increase access where the global AMR burden is most acute (see fig. 2)\, CARB-X is partnering with FIND and C-CAMP to support the diagnostic product development ecosystem in India.
URL:https://carb-x.org/event/fundamentals-of-in-vitro-diagnostic-product-development-making-the-move-from-academic-and-entrepreneurial-rd-to-product-development-webinar-series/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221029
DTSTAMP:20260403T215437
CREATED:20201203T003052Z
LAST-MODIFIED:20210309T185342Z
UID:4680-1666656000-1667001599@carb-x.org
SUMMARY:2022 Drug Discovery & Development Centre (H3D) Symposium: Celebrating a Decade of Infectious Diseases Drug Discovery and Development in Africa
DESCRIPTION:COVID Update: We are less than 8 weeks away from the H3D 2021 Symposium which was scheduled for 10th – 12th March 2021. Unfortunately\, I regret to announce that our organizing committee has decided to cancel the H3D 2021 Symposium\, which was in fact a rescheduled version of the original H3D 2020 symposium. As all of us are aware\, the COVID-19 outbreak continues to pose serious transmission risks for all face-to-face interactions\, particularly with large international events like this symposium. In addition to the transmission risk\, navigating changing regulations with regards to international travel and gatherings is quite daunting to all. Given the risks and uncertainty\, I hope that you will understand the reasoning for the cancellation. \nHowever\, I am pleased to inform you that we will be hosting a new H3D symposium from 25th-28th Oct 2022 at the same venue\, Spier Wine Estate in Stellenbosch outside of Cape Town\, South Africa. We hope you will consider joining us then. \nWelcome from Kelly Chibale\, Chair of the 2020 H3D Symposium Committee:\nI would like to extend an invitation to you to attend the 2021 Symposium hosted by the Drug Discovery & Development Centre (H3D). This will be the 4th H3D Symposium to be held in Africa (the 3rd in the Western Cape) and is a very special Symposium as it marks the 10th anniversary of the launch of H3D. Thus\, the theme of this special H3D symposium was derived as ‘Celebrating a Decade of Infectious Diseases Drug Discovery and Development’. The Symposium will cover the Centre’s research over 10 years conducted on Malaria\, Tuberculosis (TB)\, Neglected Tropical Diseases (NTDs) and drug resistant infections of bacterial origin towards combating AntiMicrobial Resistance (AMR). \nThe Symposium takes place in true Cape style at the Spier Hotel\, surrounded by leafy vineyards and beautiful mountain scenery and situated on the outskirts of the historic and picturesque old town of Stellenbosch. The organizing committee is currently encouraging participation in the symposium by drug discovery scientists from Africa\, as well from all over the globe\, who are working on the discovery of drugs to combat TB\, Malaria\, AMR and a host of NTDs. Through this symposium\, we aim to ensure that all these highly infectious\, deleterious diseases that primarily affect the African population\, will receive worldwide attention in both scientific and non-scientific arenas. \nI urge you to consider participating and making the most of this opportunity. Besides networking with the other delegates\, there will be wonderful scenery to admire and activities to enjoy. I hope that participation in this symposium will inspire your further research for the next decade! \nCARB-X participants include Erin Duffy\, Chief of R&D. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/2020-drug-discovery-development-centre-h3d-symposium-celebrating-a-decade-of-infectious-diseases-drug-discovery-and-development-in-africa/
LOCATION:Spier Hotel and Conference Centre\, Stellenbosch\, South Africa
END:VEVENT
END:VCALENDAR